Cue Biopharma Inc
NASDAQ:CUE

Watchlist Manager
Cue Biopharma Inc Logo
Cue Biopharma Inc
NASDAQ:CUE
Watchlist
Price: 0.3248 USD 34.77% Market Closed
Market Cap: 25.6m USD

Wall Street
Price Targets

CUE Price Targets Summary
Cue Biopharma Inc

There are no price targets for CUE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cue Biopharma Inc Competitors:
Price Targets
QURE
Uniqure NV
119% Upside
GNFT
Genfit SA
71% Upside
CRNX
Crinetics Pharmaceuticals Inc
70% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
ABOS
Acumen Pharmaceuticals Inc
209% Upside
BMEA
Biomea Fusion Inc
441% Upside
CRSP
CRISPR Therapeutics AG
46% Upside
CPRX
Catalyst Pharmaceuticals Inc
45% Upside

Revenue
Forecast

Revenue Estimate
Cue Biopharma Inc

The compound annual growth rate of Cue Biopharma Inc's revenue for the next 4 years is 56%.

N/A
Past Growth
56%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Cue Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Cue Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CUE's stock price target?
Not Available

CUE doesn't have any price targets made by Wall Street professionals.

What is Cue Biopharma Inc's Revenue forecast?
Projected CAGR
56%

The compound annual growth rate of Cue Biopharma Inc's revenue for the next 4 years is 56%.

Back to Top